查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886053

全球疏水交互作用層析法市場

Hydrophobic Interaction Chromatography
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球疏水交互作用層析法市場預計到2030年將達到7.163億美元

全球疏水交互作用層析法市場規模在2024年估計為4.959億美元，預計到2030年將達到7.163億美元，在分析期（2024-2030年）內複合年成長率（CAGR）為6.3%。本報告分析的細分市場之一－樹脂，預計將以7.3%的複合年成長率成長，並在分析期間結束時達到2.631億美元。緩衝液細分市場預計在分析期間將以6.3%的複合年成長率成長。

美國市場規模估計為1.289億美元，而中國市場預計將以9.6%的複合年成長率成長。

據估計，2024年美國疏水交互作用層析法市場規模將達到1.289億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到1.702億美元，在2024年至2030年的分析期內，複合年成長率（CAGR）將達到9.6%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，兩國的複合年成長率分別為3.2%和5.8%。在歐洲，德國的複合年成長率預計約為3.7%。

全球疏水交互作用層析法市場—關鍵趨勢與促進因素概述

疏水交互作用層析法能否改變蛋白質純化和生物製藥領域的模式？

疏水交互作用層析法(HIC) 是蛋白質純化中的一項重要技術，但為何它在生物製藥開發、生物化學研究和工業蛋白質生產中如此重要？疏水交互作用層析法是一種強大的技術，可根據蛋白質、胜肽和其他生物分子的疏水性進行分離和純化。在 HIC 中，生物分子被送至裝有疏水性固定相的層析管柱。透過調節流動相中的鹽濃度，研究人員可以控制蛋白質與疏水錶面的結合或洗脫方式，從而實現複雜混合物的精確分離。

疏水相互作用色譜 (HIC) 的重要性在於其能夠在不使蛋白質變性的情況下純化蛋白質，這對於維持其生物活性至關重要。這一特性使得 HIC 成為生物製藥行業的首選技術，因為在生物製藥行業中，蛋白質、抗體和其他生物分子必須經過純化才能用於治療應用。 HIC在疏水交互作用層析法為純化複雜的生物分子提供了一種可靠且高效的方法，因此在生產藥物開發、診斷和研究所需的高純度蛋白質方面發揮核心作用。

技術進步如何改善疏水交互作用層析法在生物技術和製藥應用的效果？

技術進步顯著提升了疏水交互作用層析法（ HIC）的性能，使其成為現代生物製藥和科研應用中更有效率、擴充性和適應性的技術。其中一項關鍵進展是開發出具有最佳化疏水配體的高性能樹脂和固定相。這些樹脂提高了結合特異性和容量，從而能夠更有效地分離不同疏水性的蛋白質。現代HIC樹脂具有更高的解析度，能夠純化結構密切相關的生物分子，例如蛋白質異構體和抗體變體。這在生物治療藥物生產中至關重要，因為純度是其首要考慮因素。

疏水相互作用層析 (HIC) 技術的另一項重要進展是能夠根據特定生物分子來客製化固定相的疏水性。樹脂化學的進步使得透過改變配體的類型和密度來調節疏水性成為可能，使研究人員能夠精細地控制分離過程。這種靈活性在單株抗體純化等應用中尤其重要，因為疏水性的細微差異會影響最終產品的功效。客製化的 HIC 樹脂可確保蛋白質在溫和條件下純化，從而保持其天然構象和生物活性，這對於治療性蛋白質至關重要。

自動化疏水相互作用色譜（HIC）系統已成為一項重要的技術進步，顯著提高了層析法分離過程的效率和重現性。自動化系統能夠精確控制流速、鹽梯度和柱上樣量，從而實現高度可控且可重複的分離過程。自動化減少了人為誤差和變異性，使其在大規模生物製藥生產中至關重要，因為穩定的產品純度是關鍵。將HIC整合到自動化系統中，簡化了生物製造的下游步驟，實現了更快、更擴充性的蛋白質純化工作流程。

混合模式層析法的進步，將疏水交互作用與其他分離技術（例如離子交換色譜和親和性）相結合，進一步拓展了疏水相互作用色譜（HIC）的應用範圍。這些混合技術能夠基於多種性質（例如電荷和疏水性）同時分離生物分子。混合模式HIC已被證明在純化複雜生物製藥（例如融合蛋白、抗體藥物複合體（ADC）和其他多功能治療藥物）方面尤為有效。這些進步帶來了更穩健、更靈活的純化工藝，減少了純化步驟，提高了整體生物製程效率。

為了加速疏水相互作用色譜（HIC）條件的最佳化，研究人員開發了高通量篩檢方法。這些方法使研究人員能夠並行快速評估多種樹脂類型、緩衝液條件和鹽梯度，從而確定純化特定生物分子的最佳設定。高通量技術在藥物發現的早期階段尤其重要，因為此時時間和資源效率至關重要。透過加速最佳化過程，這些技術有助於更快地將生物製藥產品推向市場，同時確保產品的高純度和高品質。

另一項重要進展是可擴展的疏水相互作用色譜（HIC）平台的開發，這些平台可以輕鬆地從實驗室規模的純化擴展到大規模工業生產。這種可擴展性在生物製藥生產中尤其重要，因為生物製藥生產需要生產大量的純化蛋白質和抗體，這就要求層析法系統能夠在規模擴大時保持性能。可擴展的HIC樹脂和系統能夠實現從研究到商業化的無縫過渡，確保純化過程的一致性和可靠性，而與生產規模無關。

為什麼疏水交互作用層析法在蛋白質純化和生物製藥生產中如此重要？

疏水交互作用層析法（ HIC）在蛋白質純化和生物製藥生產中至關重要，因為它提供了一種基於疏水交互作用分離生物分子的獨特方法，同時也能維持蛋白質的天然結構和功能。 HIC 特別重要的關鍵原因在於，它能夠在不使蛋白質暴露於可能導致其變性或惰性的惡劣條件下進行純化。許多蛋白質，尤其是用於生物製藥的蛋白質，對溫度、pH 值和離子強度的變化非常敏感。 HIC 在相對溫和的條件下進行，並使用水性緩衝體系，從而在整個純化過程中維持蛋白質的穩定性。這使其成為純化必須保持生物活性的治療性蛋白質的理想技術。

疏水相互作用層析 (HIC) 在單株抗體 (mAb) 的純化中也至關重要。單株抗體廣泛用於治療多種疾病，包括癌症和自體免疫疾病。單株抗體通常需要高度特異性的純化工藝，以確保其不含宿主細胞蛋白、DNA 和製程相關雜質等污染物。 HIC 尤其擅長將抗體與聚集體、片段和其他錯誤折疊的蛋白質分離，從而確保生產出高純度的生物療法藥物。 HIC 提供的精確性是抗體下游加工的關鍵環節，有助於提高這些藥物的安全性和有效性。

除了治療性蛋白質和抗體外，疏水性相互作用色譜 (HIC) 也用於純化疫苗成分、酵素和其他生物製藥產品。 HIC 能夠基於疏水性的細微差異分離蛋白質，因此在需要高純度分離的場合（例如重組蛋白生產）尤為重要。許多重組蛋白在宿主細胞（例如細菌或酵母）中表達，必須與含有宿主細胞蛋白和其他雜質的複雜混合物分離。 HIC 提供了一種高效的蛋白質純化方法，可在去除不需要的成分的同時，維持目標分子的活性。

HIC對生物製藥生產至關重要的另一個原因是它與其他層析法技術的兼容性。生物製程通常採用多步驟串聯層析法法以達到所需的純度。在親和性和層析法或離子交換層析法等初始純化步驟之後，HIC被廣泛用於進一步純化產品。 HIC與其他技術的互補性使其成為建構穩健純化策略的多功能工具，這些策略可根據特定生物分子進行客製化。透過將HIC與其他純化方法結合，生產商可以獲得更高的產量、更高的純度和更有效率的生產流程。

在研發領域，疏水相互作用色譜（HIC）在蛋白質表徵和結構分析中發揮重要作用。此技術可用於分析蛋白質的疏水性及其與疏水錶面的相互作用，從而深入了解蛋白質的折疊、穩定性和功能。這些見解對於藥物發現和開發至關重要，因為了解治療性蛋白質在不同條件下的行為有助於設計更有效的治療方法。此外，HIC 能夠基於疏水性分離蛋白質，使其成為研究蛋白質-蛋白質相互作用、聚集傾向以及轉譯後修飾效應的有效工具。

在工業應用中，疏水相互作用色譜 (HIC) 用於大規模純化蛋白質、酵素和其他需要嚴格品管的生物製藥。由於其擴充性和持續生產高純度產品的能力，HIC 系統在商業生物製藥生產中至關重要。隨著對生物製藥的需求不斷成長，HIC 提供了一種高效可靠的方法，既能滿足生產需求，也能確保最終產品的安全性和有效性。其在確保產品品質和一致性方面發揮關鍵作用，對於生物製藥的監管合規性和市場核准至關重要。

哪些因素正在推動疏水交互作用層析法市場的成長？

推動疏水交互作用層析法（ HIC）市場快速成長的因素有很多，包括生物製藥需求的不斷成長、蛋白質藥物研發的進步以及醫療領域對生物製藥日益成長的關注。其中一個關鍵促進因素是生物製藥產業的擴張，這帶動了對高純度蛋白質、抗體和疫苗的需求。生物製藥已成為藥物研發的重點領域，尤其是在癌症、自體免疫疾病和感染疾病的治療方面。這些生物製藥的生產需要精確且有效率的純化工藝，這也推動了對HIC系統的需求。

單株抗體在多種疾病治療的應用日益廣泛，也是推動HIC市場發展的關鍵因素。單株抗體是成長最快的治療藥物類別之一，其生產需要嚴格的純化以確保安全性和有效性。 HIC在單株抗體的純化過程中發揮關鍵作用，能夠將其與雜質、聚集體和不必要的形式分離，使其成為單株抗體生產中不可或缺的工具。隨著抗體療法市場的持續擴張，對HIC的需求也預計將隨之成長。

生物製藥產品（包括抗體藥物複合體(ADC)、融合蛋白和生物相似藥）日益複雜，也推動了疏水交互作用層析法 ( HIC) 市場的成長。這些複雜的生物製藥需要精密的純化策略才能可靠地分離不同的分子形式並達到所需的純度。 HIC 能夠基於疏水性分離蛋白質和生物分子，是純化這些先進治療藥物的理想技術。隨著生物製藥公司不斷創新並開發新型生物製藥，HIC 將在生物製劑的生產中發揮越來越重要的作用。

層析法樹脂和系統的技術進步進一步推動了疏水相互作用色譜（HIC）市場的成長。更高效、高容量樹脂的開發提高了蛋白質純化的解析度和速度，使HIC成為一種更有效率、擴充性的工業應用技術。此外，自動化系統的引入減少了人工干預，提高了實驗的重現性，使HIC更容易被企業採用。這些技術創新使得HIC對大規模生技製藥企業以及從事藥物研發的中小型生技公司都更具吸引力。

生物相似藥（與已獲核准的生物藥物高度相似的生物製藥藥物）的興起也推動了對高效純化方法（如疏水相互作用色譜法，HIC）的需求。生物相似藥生產商在尋求成本效益高的生產過程的同時，也要確保產品品質和安全性，而HIC提供了一種可靠的解決方案，可確保高純度蛋白質的生產。隨著生物相似藥在全球市場核准和應用，對HIC系統的需求預計將會成長。

最後，生物製藥監管要求日益重視產品的純度和質量，推動了對先進純化技術的需求。美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等監管機構要求生物製藥生產商證明其產品符合嚴格的純度標準。疏水相互作用色譜 (HIC) 被廣泛認為是實現這些標準的可靠有效技術，並已成為生物製藥生產過程中的關鍵組成部分。

隨著生物療法需求的成長、生物製藥行業的蓬勃發展以及蛋白質純化技術的進步，疏水交互作用層析法（ HIC）市場預計將持續擴張。生物製藥公司致力於最佳化純化流程並高效生產高純度產品，HIC 仍將是下一代生物製藥生產中不可或缺的工具。

部分：

產品及服務（樹脂、層析管、緩衝溶液及其他產品及服務）、樣本（單株抗體、疫苗及其他樣本）

受訪公司範例

  • Avantor Performance Materials LLC
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • JNC Corporation
  • Knauer GmbH
  • Merck KgaA
  • Mitsubishi Chemical Corporation
  • Sartorius AG
  • Sepax Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Waters Corporation

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具來變革市場和競爭情報。

Market Glass, Inc. 並沒有查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在國、製造地以及進出口（成品和OEM產品）情況，預測企業競爭格局的變化。這種複雜多變的市場現實將對競爭對手產生多方面的影響，包括銷貨成本增加、盈利下降和供應鏈重組，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP12505

Global Hydrophobic Interaction Chromatography Market to Reach US$716.3 Million by 2030

The global market for Hydrophobic Interaction Chromatography estimated at US$495.9 Million in the year 2024, is expected to reach US$716.3 Million by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Resins, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$263.1 Million by the end of the analysis period. Growth in the Buffers segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$128.9 Million While China is Forecast to Grow at 9.6% CAGR

The Hydrophobic Interaction Chromatography market in the U.S. is estimated at US$128.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$170.2 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Hydrophobic Interaction Chromatography Market - Key Trends and Drivers Summarized

Is Hydrophobic Interaction Chromatography the Game-Changer for Protein Purification and Biopharmaceuticals?

Hydrophobic interaction chromatography (HIC) is a vital technique in protein purification, but why is it so critical for biopharmaceutical development, biochemical research, and industrial protein production? Hydrophobic interaction chromatography is a powerful method used to separate and purify proteins, peptides, and other biomolecules based on their hydrophobicity. In HIC, biomolecules are applied to a chromatography column that contains a hydrophobic stationary phase. By manipulating the salt concentration in the mobile phase, researchers can control how proteins bind to or elute from the hydrophobic surface, allowing for precise separation of complex mixtures.

The significance of HIC lies in its ability to purify proteins without denaturing them, which is crucial for maintaining their biological activity. This makes HIC a preferred technique in the biopharmaceutical industry, where proteins, antibodies, and other biomolecules need to be purified for therapeutic use. HIC is particularly effective in downstream processing, where it is used to remove impurities and contaminants from recombinant proteins and monoclonal antibodies. By providing a reliable and efficient method for purifying complex biomolecules, hydrophobic interaction chromatography is central to the production of high-purity proteins essential for drug development, diagnostics, and research.

How Have Technological Advancements Improved Hydrophobic Interaction Chromatography for Biotech and Pharma?

Technological advancements have significantly enhanced hydrophobic interaction chromatography, making it more effective, scalable, and adaptable for modern biopharmaceutical and research applications. One of the key advancements has been the development of high-performance resins and stationary phases with optimized hydrophobic ligands. These resins improve binding specificity and capacity, allowing for more efficient separation of proteins with varying degrees of hydrophobicity. Modern HIC resins offer greater resolution, enabling the purification of closely related biomolecules, such as protein isoforms and antibody variants, which is critical in the production of biotherapeutics where purity is paramount.

Another important development in HIC technology is the ability to tailor the hydrophobicity of the stationary phase to suit specific biomolecules. Advances in resin chemistry have made it possible to adjust the degree of hydrophobicity by modifying ligand types and densities, allowing researchers to fine-tune the separation process. This flexibility is especially valuable in applications like monoclonal antibody purification, where slight variations in hydrophobicity can impact the final product’s efficacy. Tailored HIC resins ensure that proteins are purified under mild conditions, preserving their native conformation and biological activity, which is crucial for therapeutic proteins.

Automated HIC systems have also emerged as a major technological advancement, improving the efficiency and reproducibility of the chromatography process. Automated systems allow for precise control of flow rates, salt gradients, and column loading, ensuring that the separation process is highly controlled and reproducible. Automation reduces human error and variability, which is essential in large-scale biopharmaceutical production where consistency in product purity is critical. The integration of HIC into automated systems has streamlined downstream processing in biomanufacturing, allowing for faster and more scalable protein purification workflows.

Advancements in mixed-mode chromatography, which combines hydrophobic interaction with other separation techniques like ion exchange or affinity chromatography, have further expanded the applications of HIC. These hybrid approaches allow for the simultaneous separation of biomolecules based on multiple characteristics, such as charge and hydrophobicity. Mixed-mode HIC has proven especially useful in purifying complex biologics like fusion proteins, antibody-drug conjugates (ADCs), and other multimodal therapeutic agents. This advancement provides a more robust and flexible purification process, reducing the number of purification steps and enhancing overall efficiency in bioprocessing.

High-throughput screening methods have also been developed to accelerate the optimization of HIC conditions. These methods allow researchers to quickly evaluate multiple resin types, buffer conditions, and salt gradients in parallel, identifying the optimal settings for purifying a particular biomolecule. High-throughput techniques are particularly valuable in early-stage drug development, where time and resource efficiency are critical. By speeding up the process of condition optimization, these techniques help bring biopharmaceutical products to market faster while ensuring high levels of purity and quality.

Another significant advancement is the development of scalable HIC platforms that can be easily adapted from laboratory-scale purification to large-scale industrial production. This scalability is particularly important in biopharmaceutical manufacturing, where the need to produce large quantities of purified proteins or antibodies requires chromatography systems that maintain performance as they scale up. Scalable HIC resins and systems allow for a seamless transition from research to commercial production, ensuring that the purification process remains consistent and reliable, regardless of the production volume.

Why Is Hydrophobic Interaction Chromatography Critical for Protein Purification and Biopharmaceutical Production?

Hydrophobic interaction chromatography is critical for protein purification and biopharmaceutical production because it offers a unique method of separating biomolecules based on hydrophobic interactions while preserving the native structure and function of proteins. One of the main reasons HIC is so important is its ability to purify proteins without subjecting them to harsh conditions that could denature or deactivate them. Many proteins, especially those used in biopharmaceuticals, are sensitive to changes in temperature, pH, or ionic strength. HIC operates under relatively mild conditions, using aqueous buffer systems that maintain protein stability throughout the purification process. This makes it an ideal technique for purifying therapeutic proteins that need to retain their biological activity.

HIC is also crucial for the purification of monoclonal antibodies (mAbs), which are widely used in the treatment of various diseases, including cancer and autoimmune disorders. Monoclonal antibodies often require highly specific purification processes to ensure that they are free from contaminants such as host cell proteins, DNA, and process-related impurities. HIC is particularly effective in separating antibodies from aggregates, fragments, and other forms of misfolded proteins, ensuring the production of high-purity biotherapeutics. The precision offered by HIC makes it a vital part of the downstream processing of antibodies, contributing to the safety and efficacy of these drugs.

In addition to therapeutic proteins and antibodies, HIC is also used in the purification of vaccine components, enzymes, and other biopharmaceuticals. The ability of HIC to separate proteins based on subtle differences in hydrophobicity is particularly valuable in cases where high-purity separation is needed, such as in the production of recombinant proteins. Many recombinant proteins are expressed in host cells like bacteria or yeast, where they must be isolated from a complex mixture of host cell proteins and other impurities. HIC provides an efficient way to purify these proteins, removing unwanted components while maintaining the activity of the target molecule.

Another reason HIC is essential for biopharmaceutical production is its compatibility with other chromatographic techniques. In bioprocessing, multiple chromatography steps are often used in sequence to achieve the desired level of purity. HIC is commonly used after initial purification steps such as affinity chromatography or ion exchange chromatography to further refine the product. Its ability to complement other techniques makes HIC a versatile tool for building robust purification strategies that can be tailored to specific biomolecules. By integrating HIC with other purification methods, manufacturers can achieve higher yields, greater purity, and more efficient production processes.

In research and development, HIC plays a key role in protein characterization and structural studies. The technique can be used to analyze the hydrophobicity of proteins and their interaction with hydrophobic surfaces, providing valuable insights into protein folding, stability, and function. These insights are critical for drug discovery and development, where understanding the behavior of therapeutic proteins under different conditions can guide the design of more effective treatments. HIC’s ability to separate proteins based on hydrophobicity also makes it a valuable tool for studying protein-protein interactions, aggregation tendencies, and the effects of post-translational modifications.

In industrial applications, HIC is used for the large-scale purification of proteins, enzymes, and other biologics that require stringent quality control. The scalability of HIC systems, along with their ability to consistently produce high-purity products, makes them indispensable in the commercial production of biopharmaceuticals. As the demand for biologic drugs continues to grow, HIC provides an efficient and reliable method for meeting production needs while maintaining the safety and efficacy of the final product. Its role in ensuring product quality and consistency is critical for regulatory compliance and market approval of biopharmaceuticals.

What Factors Are Driving the Growth of the Hydrophobic Interaction Chromatography Market?

Several factors are driving the rapid growth of the hydrophobic interaction chromatography market, including the increasing demand for biopharmaceuticals, advancements in protein-based drug development, and the growing focus on biologics in medical treatments. One of the primary drivers is the expanding biopharmaceutical industry, where the need for high-purity proteins, antibodies, and vaccines is growing. Biologics have become a key area of focus in drug development, particularly in therapies for cancer, autoimmune diseases, and infectious diseases. As the production of these biologics requires precise and efficient purification processes, the demand for HIC systems is rising.

The growing adoption of monoclonal antibodies in the treatment of various medical conditions is another significant factor driving the HIC market. Monoclonal antibodies are among the fastest-growing classes of therapeutic drugs, and their production requires rigorous purification to ensure safety and efficacy. HIC plays a critical role in purifying monoclonal antibodies by separating them from impurities, aggregates, and unwanted forms, making it an indispensable tool in their manufacturing. As the market for antibody-based therapies continues to expand, the demand for HIC is expected to rise accordingly.

The increasing complexity of biopharmaceutical products, such as antibody-drug conjugates (ADCs), fusion proteins, and biosimilars, is also contributing to the growth of the hydrophobic interaction chromatography market. These complex biologics require sophisticated purification strategies to ensure the separation of different molecular forms and achieve the desired purity levels. HIC’s ability to resolve proteins and biomolecules based on their hydrophobicity makes it an ideal technique for purifying these advanced therapeutics. As biopharmaceutical companies continue to innovate and develop new classes of biologic drugs, HIC will play an increasingly important role in their production.

Technological advancements in chromatography resins and systems are further fueling the growth of the HIC market. The development of more efficient and high-capacity resins has improved the resolution and speed of protein purification, making HIC more effective and scalable for industrial use. In addition, the integration of automated systems has made HIC more accessible to companies by reducing manual intervention and improving reproducibility. These technological innovations are making HIC a more attractive option for both large-scale biopharmaceutical manufacturers and smaller biotech firms engaged in drug development.

The rise of biosimilars-biopharmaceutical products that are highly similar to already-approved biologics-is also driving demand for efficient purification methods like HIC. As biosimilar manufacturers seek to develop cost-effective production processes while maintaining the quality and safety of their products, HIC offers a reliable solution for ensuring high-purity protein production. With the growing approval and adoption of biosimilars in global markets, the demand for HIC systems is expected to increase.

Lastly, regulatory requirements for biopharmaceuticals are placing greater emphasis on product purity and quality, driving the need for advanced purification technologies. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require biopharmaceutical manufacturers to demonstrate that their products meet stringent purity standards. HIC is widely recognized as a robust and reliable technique for achieving these standards, making it a critical component of the biomanufacturing process.

With the rising demand for biologic therapies, the growth of the biopharmaceutical industry, and advancements in protein purification technologies, the hydrophobic interaction chromatography market is poised for continued expansion. As biopharmaceutical companies seek to optimize their purification workflows and produce high-purity products efficiently, HIC will remain an essential tool in the production of next-generation biologics.

SCOPE OF STUDY:

The report analyzes the Hydrophobic Interaction Chromatography market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Services (Resins, Columns, Buffers, Other Product & Services); Sample (Monoclonal Antibodies, Vaccines, Other Samples)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 11 Featured) -

  • Avantor Performance Materials LLC
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • JNC Corporation
  • Knauer GmbH
  • Merck KgaA
  • Mitsubishi Chemical Corporation
  • Sartorius AG
  • Sepax Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Waters Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Hydrophobic Interaction Chromatography - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Biopharmaceutical Purification and Separation Drives Growth in Hydrophobic Interaction Chromatography Market
    • Expansion of Protein and Antibody-based Therapeutics Spurs Adoption of Hydrophobic Interaction Chromatography
    • Growth in Focus on Improving Protein Separation and Purification Efficiency Expands Addressable Market for Hydrophobic Interaction Chromatography
    • Role of Hydrophobic Interaction Chromatography in Enhancing Downstream Bioprocessing Strengthens Business Case for Adoption
    • Increasing Focus on Chromatography Solutions for Monoclonal Antibodies and Vaccines Fuels Market Demand
    • Increasing Focus on Chromatography Solutions for Gene Therapy and Viral Vector Production Expands Addressable Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hydrophobic Interaction Chromatography Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Resins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Columns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Columns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Columns by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Buffers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Product & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Product & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Product & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • JAPAN
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • CHINA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • EUROPE
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • FRANCE
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • GERMANY
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • INDIA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • AFRICA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030

IV. COMPETITION